Suggestions
Scott Briggs
Principal at Putnam Associates
Professional Background
Scott Briggs is a highly experienced strategy consultant with a remarkable background in the life sciences sector. Currently serving as a Principal at Putnam, a preeminent global consulting firm, Scott specializes in Value Proposition and Commercial Strategy for pharmaceutical and biotechnology companies. His in-depth knowledge and strategic acumen have allowed him to excel in formulating tailored solutions that meet the complex needs of his clients in the competitive life sciences landscape.
Scott's career trajectory is marked by progressive responsibility at Putnam, where he has held multiple roles from Associate Consultant to Senior Consultant and Manager. This steadfast path illustrates his commitment to not only meet but anticipate the evolving demands of the pharmaceutical industry. His insights have been instrumental in navigating various phases of drug commercialization and launch strategy, making him a trusted advisor to his clients.
Prior to his tenure at Putnam, Scott amassed valuable experience through internships and positions at reputable organizations such as BioMarin Pharmaceuticals and Ionis Pharmaceuticals. As a Pipeline Commercialization Intern at BioMarin, he contributed to pivotal projects aimed at bringing novel therapies to market, honing his skills in understanding both the scientific and commercial aspects of drug development.
Moreover, his early career experiences, including a role as an Antisense Drug Discovery Intern at Ionis Pharmaceuticals and a Researcher position at the Duke Institute for Brain Sciences, provided him a solid foundation in pharmacology and scientific research. Such roles have enabled him to achieve a nuanced understanding of how scientific principles translate into marketable healthcare solutions.
Education and Achievements
Scott Briggs's educational background is noteworthy. He earned his Bachelor of Science in Biology with a concentration in Pharmacology from Duke University, graduating in 2014. This rigorous academic training laid the groundwork for his analytical skills and understanding of biological sciences, which are crucial for his current role in strategy consulting focused on life sciences.
Furthering his academic pursuits, Scott attended Harvard Business School, where he obtained his Master of Business Administration (MBA) in 2020. This prestigious program refined his business acumen, enabling him to marry scientific knowledge with business strategy effectively. The combination of his strong scientific background and business training distinguishes Scott in the consulting field, particularly within pharmaceutical and biotech sectors.
Achievements
Scott has achieved numerous milestones throughout his career. His strategic projects at Putnam have resulted in successful commercialization strategies for various pharmaceutical products, demonstrating his ability to drive results in a challenging marketplace. His work has directly contributed to the successful launch of innovative therapies, providing substantial value to clients and ultimately benefiting patients worldwide.
As a thought leader in the consulting space, Scott has engaged in various professional forums and discussions, sharing insights on market strategies and trends in the life sciences industry. His professional engagements reflect a commitment not only to his personal development but also to the advancement of the broader consulting profession in life sciences.
tags':['strategy consultant','life sciences','pharmaceutical strategy','biotechnology','VPA','commercial strategy','Putnam Associates','MBA','Harvard Business School','Duke University','BioMarin Pharmaceuticals','Ionis Pharmaceuticals','consulting','drug commercialization','pipeline commercialization','research','CDC','Duke Institute for Brain Sciences'],
questions':['How did Scott Briggs develop his expertise in pharmaceutical and biotechnology strategy consulting?','What specific projects has Scott Briggs led at Putnam that contributed to successful pharmaceutical product launches?','In what ways does Scott Briggs leverage his educational background in biology and business in his consulting work?','How has Scott Briggs’s previous experience at BioMarin and Ionis shaped his approach to consulting in the life sciences sector?','What are the key challenges Scott Briggs faces as a Principal at Putnam, and how does he overcome them?'],
title
